Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Publication Title
European urology
Document Type
Article
Publication Date
5-21-2024
Keywords
oregon; chiles
Clinical Institute
Cancer
Specialty
Oncology
Recommended Citation
Lee, Chung-Han; Yogesh Shah, Amishi; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Gironés Sarrió, Regina; Lee Cohn, Allen; Asim Bilen, Mehmet; Gunnestad Ribe, Sara; Krohn Tennøe, Øyvind; Richards, Donald; Sweis, Randy F; Courtright, Jay; Heinrich, Daniel; Perini, Rodolfo; Kubiak, Peter; Bock, Daena; Okpara, Chinyere E; and Motzer, Robert J, "Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146." (2024). Articles, Abstracts, and Reports. 8835.
https://digitalcommons.providence.org/publications/8835